STERIS plc $STE Stock Holdings Lowered by Federated Hermes Inc.

Federated Hermes Inc. cut its position in STERIS plc (NYSE:STE) by 41.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 191,195 shares of the medical equipment provider’s stock after selling 137,115 shares during the quarter. Federated Hermes Inc.’s holdings in STERIS were worth $45,929,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Spurstone Advisory Services LLC bought a new stake in shares of STERIS during the second quarter valued at approximately $29,000. Geneos Wealth Management Inc. grew its holdings in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares in the last quarter. Zions Bancorporation National Association UT acquired a new stake in STERIS in the 1st quarter valued at approximately $37,000. Loomis Sayles & Co. L P bought a new stake in STERIS during the 2nd quarter valued at $54,000. Finally, Generali Investments Management Co LLC bought a new stake in STERIS during the 2nd quarter valued at $56,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Daniel A. Carestio sold 159 shares of the business’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $241.82, for a total transaction of $38,449.38. Following the sale, the chief executive officer directly owned 51,096 shares of the company’s stock, valued at $12,356,034.72. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP John Adam Zangerle sold 15,000 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the completion of the transaction, the vice president owned 33,669 shares of the company’s stock, valued at $8,926,998.66. This trade represents a 30.82% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 25,203 shares of company stock valued at $6,624,667 over the last ninety days. 1.07% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently issued reports on STE. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, STERIS presently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

STERIS Stock Down 0.8%

NYSE STE opened at $261.29 on Tuesday. STERIS plc has a 12 month low of $200.98 and a 12 month high of $268.60. The company has a market capitalization of $25.65 billion, a P/E ratio of 37.54 and a beta of 1.01. The company’s 50 day simple moving average is $250.32 and its 200 day simple moving average is $243.52. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.09. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same quarter in the previous year, the business posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities research analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s payout ratio is 36.21%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.